$5750 | Single User
$11500 | Site License
$17250 | Enterprise License

Chronic Heart Failure - Market Insights, Epidemiology and Market Forecast – 2025 [Report Updated: 10-07-2017]

Published by Delve Insight: 10 Jul 2017 | 105394 | In Stock

Introduction

DelveInsight’s “Chronic Heart Failure - Market Insights, Epidemiology and Market Forecast – 2025” Reports provides an overview of the disease and global market size of the Chronic Heart Failure for the 7MM (United States, Germany, France, Italy, Spain and UK). The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Chronic Heart Failure forecasted market share for ten years to 2025 segmented by seven major markets. In addition, the report includes the historical and forecasted epidemiological data for the diagnosed prevalent cases of Chronic Heart Failure till 2025.

The report provides a detailed analysis and in-depth coverage of both current and emerging therapies. The report also covers the unmet need, market barriers and drivers of the Chronic Heart Failure market.

According to DelveInsight, the forecasted patient population of Chronic Heart Failure for the year 2025 will be XX increasing at a CAGR of XX% from 2015 to 2025 and the Chronic Heart Failure 7MM market size is estimated to be USD XX by 2025.

The DelveInsight Report will help in understanding the Chronic Heart Failure market from the inside out, with transparency into the calculated patient forecasting data and estimated market size.

Key Coverage and Benefits:

The report will help in developing business strategies by understanding the trends shaping and driving the global Chronic Heart Failure market.

Understanding the global historical and forecasted epidemiological data covering 7MM from 2015-2025.

Organize sales and marketing efforts by identifying the best opportunities for Chronic Heart Failure in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

To understand the future market competition in the global Chronic Heart Failure market and Insightful review of the key market drivers and barriers.

The Report also covers the detailed global historical and forecasted Chronic Heart Failure market covering United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2015-2025.

Chronic Heart Failure Market (7MM)

Chronic Heart Failure Market forecasting

Chronic Heart Failure Sales forecasting

Chronic Heart Failure Market segments

Chronic Heart Failure Epidemiology

Chronic Heart Failure Pipeline products and technologies

Chronic Heart Failure Competitive landscape

Chronic Heart Failure SWOT analysis

Chronic Heart Failure Market Driver’s and barriers

Chronic Heart Failure Key Companies and Funding

Table of Contents
for Chronic Heart Failure - Market Insights, Epidemiology and Market Forecast – 2025 [Report Updated: 10-07-2017]

  • Report Introduction

    Chronic Heart Failure Market Overview at a Glance

    Total Market Share Distribution of Chronic Heart Failure for 7 MM in 2016

    Total Market Share Distribution of Chronic Heart Failure for 7 MM in 2025

    Chronic Heart Failure

    Overview

    Symptoms

    Pathophysiology

    Staging

    Diagnosis

    Treatment

    Epidemiology and Patient Population

    United States

    Diagnosed Cases of Chronic Heart Failure in United States

    Germany

    Diagnosed Cases of Chronic Heart Failure in Germany

    France

    Diagnosed Cases of Chronic Heart Failure in France

    Italy

    Diagnosed Cases of Chronic Heart Failure in Italy

    Spain

    Diagnosed Cases of Chronic Heart Failure in Spain

    United Kingdom

    Diagnosed Cases of Chronic Heart Failure in United Kingdom

    Treatment Algorithm

    Treatment Guidelines/Practices

    Marketed Drugs for Chronic Heart Failure

    Drug 1: Company A

    Drug Description

    Mechanism of Action

    Regulatory Milestones

    Advantages & Disadvantages

    Safety and Efficacy

    Product Profile

    Patent Status

    Drug 2: Company B

    Drug Description

    Mechanism of Action

    Regulatory Milestones

    Advantages & Disadvantages

    Safety and Efficacy

    Product Profile

    Patent Status

    Emerging Therapies

    Drug 3: Company C

    Description

    Regulatory Milestones

    Advantages & Disadvantages

    Product Profile

    Launch Date

    Clinical Development

    Clinical Pipeline Activity

    Ongoing Trials Information

    Clinical Trial by Phase

    Drug 4: Company B

    Description

    Regulatory Milestones

    Advantages & Disadvantages

    Product Profile

    Launch Date

    Clinical Development

    Clinical Pipeline Activity

    Ongoing Trials Information

    Clinical Trial by Phase

    Overview of Total Chronic Heart Failure Market (2016 & 2025)

    Chronic Heart Failure: Country-Wise Market Analysis

    United States

    Historical Market Size (2015-2016)

    Forecasted Market Size (2017-2025)

    Germany Market Size

    Historical Market Size (2015-2016)

    Forecasted Market Size (2017-2025)

    France Market Size

    Historical Market Size (2015-2016)

    Forecasted Market Size (2017-2025)

    United Kingdom Market Size

    Historical Market Size (2015-2016)

    Forecasted Market Size (2017-2025)

    Spain Market Size

    Historical Market Size (2015-2016)

    Forecasted Market Size (2017-2025)

    Italy Market Size

    Historical Market Size (2015-2016)

    Forecasted Market Size (2017-2025)

    Japan Market Size

    Historical Market Size (2015-2016)

    Forecasted Market Size (2017-2025)

    Market Drivers

    Market Restraints

    Appendix

    Report Methodology

    Consulting Services

    Disclaimer

    About DelveInsight

List Of Tables
in Chronic Heart Failure - Market Insights, Epidemiology and Market Forecast – 2025 [Report Updated: 10-07-2017]

Table 1: Diagnosed Cases Chronic Heart Failure in United States (2015-2025)

Table 2: Diagnosed Cases Chronic Heart Failure in Germany (2015-2025)

Table 3: Diagnosed Cases Chronic Heart Failure in France (2015-2025)

Table 4: Diagnosed Cases Chronic Heart Failure in United Kingdom (2015-2025)

Table 5: Diagnosed Cases Chronic Heart Failure in Spain (2015-2025)

Table 6: Diagnosed Cases Chronic Heart Failure in Italy (2015-2025)

Table 7: Diagnosed Cases Chronic Heart Failure in Japan (2015-2025)

Table 8: List of Marketed Drugs for Chronic Heart Failure

Table 9: List of Pipeline Phase III Drugs for Chronic Heart Failure

Table 10: Drug 1, Clinical Trials by Zone, 2017

Table 11: Clinical Trials by Trial status, 2017

Table 12: Drug 2, Clinical Trials by Zone, 2017

Table 13: Clinical Trials by Trial status, 2017

Table 14: Drug 3, Clinical Trials by Zone, 2017

Table 15: Clinical Trials by Trial status, 2017

Table 16: United States Market Size of Chronic Heart Failure in USD, Million (2015-2025)

Table 17: Germany Market Size of Chronic Heart Failure in USD, Million (2015-2025)

Table 18: France Market Size of Chronic Heart Failure in USD, Million (2015-2025)

Table 19: United Kingdom Market Size of Chronic Heart Failure in USD, Million (2015-2025)

Table 20: Spain Market Size of Chronic Heart Failure in USD, Million (2015-2025)

Table 21: Italy Market Size of Chronic Heart Failure in USD, Million (2015-2025)

Table 22: Japan Market Size of Chronic Heart Failure in USD, Million (2015-2025)

List Of Figures, Charts and Diagrams
in Chronic Heart Failure - Market Insights, Epidemiology and Market Forecast – 2025 [Report Updated: 10-07-2017]

Figure 1: Diagnosed Cases Chronic Heart Failure in United States (2015-2025)

Figure 2: Diagnosed Cases Chronic Heart Failure in Germany (2015-2025)

Figure 3: Diagnosed Cases Chronic Heart Failure in France (2015-2025)

Figure 4: Diagnosed Cases Chronic Heart Failure in United Kingdom (2015-2025)

Figure 5: Diagnosed Cases Chronic Heart Failure in Spain (2015-2025)

Figure 6: Diagnosed Cases Chronic Heart Failure in Italy (2015-2025)

Figure 7: Diagnosed Cases Chronic Heart Failure in Japan (2015-2025)

Figure 8: List of Marketed Drugs for Chronic Heart Failure

Figure 9: List of Pipeline Phase III Drugs for Chronic Heart Failure

Figure 10: Drug 1, Clinical Trials by Zone (%), 2017

Figure 11: Clinical Trials by Trial status, 2017

Figure 12: Drug 2, Clinical Trials by Zone (%), 2017

Figure 13: Clinical Trials by Trial status, 2017

Figure 14: Drug 3, Clinical Trials by Zone (%), 2017

Figure 15: Clinical Trials by Trial status, 2017

Figure 16: United States Market Size of Chronic Heart Failure in USD, Million (2015-2025)

Figure 17: Germany Market Size of Chronic Heart Failure in USD, Million (2015-2025)

Figure 18: France Market Size of Chronic Heart Failure in USD, Million (2015-2025)

Figure 19: United Kingdom Market Size of Chronic Heart Failure in USD, Million (2015-2025)

Figure 20: Spain Market Size of Chronic Heart Failure in USD, Million (2015-2025)

Figure 21: Italy Market Size of Chronic Heart Failure in USD, Million (2015-2025)

Figure 22: Japan Market Size of Chronic Heart Failure in USD, Million (2015-2025)

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

105394 | DIMI0055

Number of Pages

70

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Global Chronic Kidney Disease Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
The Outlook for Wearable Health Tech in Managing Chronic Disease
IntroductionWearable tech – the new golden ticket for patient adherence?Wearable technology is being...
01 May 2016 by FirstWord Pharma USD $695 More Info
Chronic Obstructive Pulmonary Disorder (COPD): Update Bulletin [Feb 2016]
IntroductionThis edition presents key opinion leader (KOL) views on recent developments in the chron...
01 Feb 2016 by FirstWord Pharma USD $995 More Info
Chronic Lymphocytic Leukaemia: Update Bulletin [Feb 2016]
IntroductionGain new KOL insights on the latest events with the potential to shape the targeted trea...
01 Feb 2016 by FirstWord Pharma USD $995 More Info
Chronic Lymphocytic Leukaemia: KOL Insight
IntroductionIn the last few years the emergence of new targeted therapies such as AbbVie’s/Janssen’s...
01 Sep 2015 by FirstWord Pharma USD $7,900 More Info
Chronic Obstructive Pulmonary Disorder (COPD): KOL Insight
IntroductionCombination therapy is set to take centre stage in the treatment of COPD as leading comp...
20 Apr 2015 by FirstWord Pharma USD $7,900 More Info
Chronic Lymphocytic Leukaemia: KOL Insight
IntroductionChronic lymphocytic leukaemia (CLL) is the most common of the leukaemias, but until rece...
27 May 2014 by FirstWord Pharma USD $7,900 More Info
Chronic Obstructive Pulmonary Disorder (COPD) - KOL Insight and Consensus Outlook
IntroductionThe prevalence of Chronic Obstructive Pulmonary Disorder (COPD) is increasing globally, ...
20 Jan 2014 by FirstWord Pharma USD $7,495 More Info
Physician Views: Life after Gleevec in the chronic myeloid leukaemia (CML) market?
ScopeNovartis' Gleevec is widely credited as being one of the most important drug launches of all ti...
01 Jun 2013 by FirstWord Pharma USD $695 More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Download Free Report Summary PDF

Chronic Heart Failure - Market Insights, Epidemiology and Market Forecast – 2025 [Report Updated: 10-07-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data